Medicare Enrolled

Dr. Charles Rheeman, MD

Ophthalmology · Malta, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
658 MALTA AVE, Malta, NY 12020
5185800553
In practice since 2006 (20 years)
NPI: 1073572236 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rheeman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rheeman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rheeman

Dr. Charles Rheeman is an ophthalmology specialist in Malta, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rheeman performed 2,269 Medicare services across 1,768 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rheeman received a total of $35,841 from 29 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rheeman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 42% volume in NY $35,841 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,269
Medicare services
Top 42% in NY for ophthalmology
1,768
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
525 $44 $199
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
463 $63 $227
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
409 $24 $139
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
340 $80 $384
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
130 $23 $243
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
113 $87 $334
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
97 $119 $513
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
49 $28 $140
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
33 $68 $335
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
26 $102 $463
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
22 $21 $90
Visual field test, intermediate
A test that measures your side vision to check for blind spots or other vision changes.
22 $32 $139
Eye deviation and range of motion exam
An examination to measure eye deviation and assess the range of motion of the eyes.
15 $43 $191
Eye photography
Photographic imaging of the interior structures of the eye.
13 $14 $130
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
12 $8 $90
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$35,841
Total received (2018-2024)
Avg $5,120/year across 7 years
Top 5% in NY for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,604 (79.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,238 (20.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$26,693
2023
$2,148
2022
$4,146
2021
$1,392
2020
$452
2019
$639
2018
$372

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$25,403
Bausch & Lomb Americas Inc.
$536
Oyster Point Pharma, Inc.
$230
Mallinckrodt Hospital Products Inc.
$217
Astellas Pharma US Inc
$157
ABBVIE INC.
$54
Alcon Vision LLC
$41
Genentech USA, Inc.
$31
Apellis Pharmaceuticals, Inc.
$24
Top 3 companies account for 98.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$25,403
Horizon Therapeutics plc
$5,203
Mallinckrodt Hospital Products Inc.
$1,546
Bausch & Lomb Americas Inc.
$747
Oyster Point Pharma, Inc.
$514
Allergan Inc.
$452
Novartis Pharmaceuticals Corporation
$433
Aerie Pharmaceuticals, Inc.
$326
Alcon Vision LLC
$166
Astellas Pharma US Inc
$157
Mallinckrodt Enterprises LLC
$157
Omeros Corporation
$121
Alexion Pharmaceuticals, Inc.
$72
ABBVIE INC.
$72
TissueTech, Inc.
$70
Sun Pharmaceutical Industries Inc.
$63
Shire North American Group Inc
$62
Regeneron Healthcare Solutions, Inc.
$53
Genentech USA, Inc.
$47
Exeltis, USA Inc.
$24
Apellis Pharmaceuticals, Inc.
$24
EyePoint Pharmaceuticals US, Inc.
$23
ARGENX US, INC.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Spark Therapeutics, Inc.
$15
Bausch & Lomb, a division of Bausch Health US, LLC
$14
Sight Sciences, Inc.
$13
Alimera Sciences, Inc.
$13
Heidelberg Engineering, Inc.
$10
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BROMSITE · CEQUA · Cequa · EYLEA · ILUVIEN · Izervay · LOTEMAX · LUMIGAN · MIEBO · OMIDRIA · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · PURIFIED CORTROPHIN GEL · Prokera · RESTASIS · Rhopressa · Rocklatan · Soliris · Spectralis · Syfovre · TEPEZZA · TYRVAYA · UPLIZNA · VABYSMO · VYVGART · VYZULTA · Vabysmo · XIIDRA · YUTIQ · enVista MX60 IOL · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in NY.

Looking for an ophthalmology specialist in Malta?
Compare ophthalmologists in the Malta area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
96
Per 100K population
40.5
County median income
$99,653
Nearest hospital
SARATOGA HOSPITAL
8.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rheeman is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rheeman experienced with visual field test, extended?
Based on Medicare claims data, Dr. Rheeman performed 525 visual field test, extended services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rheeman receive payments from pharmaceutical companies?
Yes. Dr. Rheeman received a total of $35,841 from 29 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rheeman's costs compare to other ophthalmologists in Malta?
Dr. Rheeman's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rheeman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →